Stock Analysis on Net
Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

Common-Size Balance Sheet: Assets

Merck & Co. Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cash and cash equivalents 11.31 6.41 11.63 7.66 8.80
Short-term investments 0.38 0.24 0.46 0.00 0.00
Accounts receivable, net of allowance for doubtful accounts 8.78 9.70 8.66 8.73 8.57
Inventories, excludes inventories classified in Other assets 5.22 5.96 5.41 5.63 6.89
Other current assets 7.43 7.84 6.57 6.61 6.05
Current assets 33.12% 30.16% 32.72% 28.64% 30.31%
Investments 0.40 0.24 0.93 0.35 0.86
Property, plant and equipment, at cost, net of accumulated depreciation 20.31 21.61 19.62 18.24 19.64
Goodwill 18.50 19.87 19.42 20.12 22.10
Other intangibles, net 13.98 16.88 18.57 21.70 15.95
Other assets 13.70 11.25 8.73 10.96 11.15
Noncurrent assets 66.88% 69.84% 67.28% 71.36% 69.69%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Merck & Co. Inc. current assets as a percentage of total assets decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Property, plant and equipment, at cost, net of accumulated depreciation Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Merck & Co. Inc. property, plant and equipment, at cost, net of accumulated depreciation as a percentage of total assets increased from 2022 to 2023 but then slightly decreased from 2023 to 2024 not reaching 2022 level.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Merck & Co. Inc. noncurrent assets as a percentage of total assets increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.